Home    Back

Trametinib tablet    (DrugBank: Trametinib)

1 disease
IDDisease name (Link within this page)Number of trials
279Huge venous malformation with cervical, oral and pharyngeal diffuse lesion1

279. Huge venous malformation with cervical, oral and pharyngeal diffuse lesion    [ 12 clinical trials,   23 drugs,   (DrugBank: 9 drugs),   3 drug target genes,   103 drug target pathways]
Searched query = "Huge venous malformation with cervical, oral and pharyngeal diffuse lesion", "Huge venous malformation", "Venous malformation"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 12 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT04258046
(ClinicalTrials.gov)		March 31, 202016/1/2020Trametinib in the Treatment of Complicated Extracranial Arterial Venous MalformationPhase II Clinical Trial of MEK Inhibitor Trametinib in the Treatment of Complicated Extracranial Arterial Venous Malformation (VM)Venous Malformation;Arterial DiseaseDrug: Trametinib tabletStanford UniversityBoston Children's HospitalNot yet recruiting12 Years60 YearsAll30Phase 2United States